These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 14665637

  • 1. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
    Nguyen TM, Lieberherr M, Fritsch J, Guillozo H, Alvarez ML, Fitouri Z, Jehan F, Garabédian M.
    J Biol Chem; 2004 Feb 27; 279(9):7591-7. PubMed ID: 14665637
    [Abstract] [Full Text] [Related]

  • 2. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D.
    Nguyen TM, Adiceam P, Kottler ML, Guillozo H, Rizk-Rabin M, Brouillard F, Lagier P, Palix C, Garnier JM, Garabedian M.
    J Bone Miner Res; 2002 Sep 27; 17(9):1728-37. PubMed ID: 12211444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3.
    Nguyen M, d'Alesio A, Pascussi JM, Kumar R, Griffin MD, Dong X, Guillozo H, Rizk-Rabin M, Sinding C, Bougnères P, Jehan F, Garabédian M.
    J Bone Miner Res; 2006 Jun 27; 21(6):886-94. PubMed ID: 16753019
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor.
    Malloy PJ, Wang J, Srivastava T, Feldman D.
    Mol Genet Metab; 2010 Jan 27; 99(1):72-9. PubMed ID: 19815438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
    Griffin JE, Zerwekh JE.
    J Clin Invest; 1983 Oct 27; 72(4):1190-9. PubMed ID: 6313754
    [Abstract] [Full Text] [Related]

  • 11. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS.
    Exp Cell Res; 2002 Jun 10; 276(2):320-7. PubMed ID: 12027461
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.
    Armbrecht HJ, Hodam TL, Boltz MA.
    Arch Biochem Biophys; 2003 Jan 15; 409(2):298-304. PubMed ID: 12504896
    [Abstract] [Full Text] [Related]

  • 14. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
    Nishimura A, Shinki T, Jin CH, Ohyama Y, Noshiro M, Okuda K, Suda T.
    Endocrinology; 1994 Apr 15; 134(4):1794-9. PubMed ID: 8137744
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S, Martel J, Tenenhouse HS.
    J Bone Miner Res; 1995 Dec 15; 10(12):1951-9. PubMed ID: 8619376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
    Li XY, Boudjelal M, Xiao JH, Peng ZH, Asuru A, Kang S, Fisher GJ, Voorhees JJ.
    Mol Endocrinol; 1999 Oct 15; 13(10):1686-94. PubMed ID: 10517670
    [Abstract] [Full Text] [Related]

  • 20. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML, Ray S, Swamy N, Holick MF, Ray R.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):34-44. PubMed ID: 10496974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.